DarioHealth Q2 EPS $(0.58) Misses $(0.52) Estimate, Sales $6.15M Miss $6.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
DarioHealth (NASDAQ:DRIO) reported Q2 losses of $(0.58) per share, missing the analyst consensus estimate of $(0.52) by 11.54%. The company also reported quarterly sales of $6.15 million, missing the analyst consensus estimate of $6.46 million by 4.80%. This represents a 21.62% increase in losses and a 0.53% decrease in sales compared to the same period last year.
August 10, 2023 | 10:16 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DarioHealth's Q2 earnings missed analyst estimates, with higher losses and lower sales than expected. This could negatively impact the company's stock price in the short term.
DarioHealth's Q2 earnings report shows higher than expected losses and lower than expected sales. This negative financial performance could lead to a decrease in investor confidence, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100